Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Clinical Data
  • Kainova expands DT 7012 trial into Europe
  • Clinical Data

Kainova expands DT 7012 trial into Europe

PharmaTimes

First patient dosed as DOMISOL study grows beyond Australia

Clinical DataOncologyRead full story

pharminent April 9, 2026 (Last updated: April 9, 2026)

PharmaTimes

First patient dosed as DOMISOL study grows beyond Australia

Clinical DataOncologyRead full story

Post navigation

Previous: Roche sticks with C4T, adding up to $1B for molecular glue partnership
Next: Innovent’s CDMO gets green light to make biologics at large Chinese plant

Related Stories

  • Clinical Data

Novo Nordisk starts trialing lower maintenance doses of oral Wegovy

pharminent August 21, 2026
  • Clinical Data

Cancer vaccine win restores Wall Street’s faith in Moderna

pharminent August 20, 2026
  • Clinical Data

New Taiho, Cullian data heats up lung cancer drug battle

pharminent August 13, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.